What Is The Forecast Valuation Of The Global Acute Coronary Syndrome Market Projected To Reach $13.43 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Acute Coronary Syndrome Market Today And What Is Its Future Size?
The market size for acute coronary syndrome has seen substantial growth in the recent past. Its progression is predicted to be from $9.86 billion in 2024 to $10.43 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth throughout the historic period include public health initiatives, the increasing use of telemedicine and remote monitoring, advancements in emergency medical services, and a rising demand for patient education.
The market size for acute coronary syndrome is anticipated to experience robust growth in the coming years, projected to escalate to $13.43 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. Several factors such as the rising demand for personalized healthcare, advances in interventional cardiology, growing awareness, and the increasing global elderly population contribute to the growth in the forecast period. Significant emerging trends during this period includes the progress in diagnostic tools, incorporation of health IT, swift response systems, and technological progressions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12985&type=smp
Which Key Factors Are Fueling Growth In The Acute Coronary Syndrome Market?
The escalation in instances of chronic illnesses like coronary artery disease, ischemic heart disease, and vascular diseases is projected to stimulate the expansion of the acute coronary syndrome market in the future. Ischemic heart disease presents as a long-term ailment stemming from the blockage or constriction of the coronary arteries. Acute coronary syndrome (ACS) treatment is designed to alleviate symptoms promptly, minimize cardiac damage, and avert further complications in patients experiencing various acute coronary syndromes, inclusive of ischemic heart disease and vascular diseases. For example, a study published in the Journal of the American College of Cardiology in August 2022 revealed that all four cardiovascular risk factors among the general U.S. population are projected to escalate between 2025 and 2060, with dyslipidemia increasing by 27.6% and hypertension by 25.1%. According to the research, heart failure (33.4%) and ischemic heart disease (30.7%) are projected to have the largest rate increases, succeeded by heart attack (16.9%) and stroke (33.8%). Consequently, the occurrence of chronic diseases like coronary artery disease, ischemic heart disease, and vascular diseases bolsters the acute coronary syndrome market.
How Is The Acute Coronary Syndrome Market Segmented Across Key Categories?
The acute coronary syndromemarket covered in this report is segmented –
1) By Type: Non-St-Elevation Myocardial Infarction; St-Elevation Myocardial Infarction; Unstable Angina
2) By Treatment: Medications; Statins; Beta blockers; ACE inhibitors; Anticoagulants; Other Treatment
3) By Diagnosis: Stress Test; Blood Tests; Imaging; Other Diagnosis
4) By Route Of Administration: Oral; Parenteral
5) By End-User: Hospitals; Specialty clinics; Other End User
Subsegments:
1) By Non-ST-Elevation Myocardial Infarction: Medical Management; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG)
2) By ST-Elevation Myocardial Infarction: Medical Management; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG)
3) By Unstable Angina: Medical Management; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG)
What Future-Focused Trends Are Anticipated In The Acute Coronary Syndrome Market?
Leading businesses in the acute coronary syndrome market are focusing on the formulation of innovative medications to maintain their market standing. Drug advancements potentially enhance the effectiveness of ACS treatment, thus diminishing the time and resources needed per patient. For example, AGEPHA Pharma USA LLC, an American pharmaceutical organization, introduced Lodoco in June 2023, a product sanctioned by the American government agency, the Food and Drug Administration (FDA). This is the initial anti-inflammatory atheroprotective cardiovascular therapy that minimizes the risk of heart stroke, coronary revascularization, myocardial infarction (MI), and cardiovascular mortality in adult patients suffering from cardiovascular disorders, including acute coronary syndrome.
Who Are The Leading Companies Driving The Acute Coronary Syndrome Market?
Major companies operating in the acute coronary syndrome market are Pfizer Inc., Johnson and Johnson Limited, Siemens AG, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Stryker Corporation, GE Healthcare Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Terumo Corp., BioMérieux SA, Beckman Coulter Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Biotronik Inc., Randox Laboratories Limited, Nihon Kohden Corporation, Trinity Biotech plc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report
Which Region Dominates The Acute Coronary Syndrome Market Today?
North America was the largest region in the acute coronary syndrome market in 2024. The regions covered in acute coronary syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12985&type=smp
Browse Through More Reports Similar to the Global Acute Coronary Syndrome Market 2025, By The Business Research Company
Cardiac Assist Devices And Equipment Global Market Report 2025
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
Cardiac Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
